New Cefovecin Sodium Injectable Therapy Available in the US
A generic, long-acting, injectable antibiotic for the treatment of canine and feline skin infections has been launched by Dechra.
Solovecin, a cefovecin sodium product, is available in the US through all major distributors, according to the veterinary pharmaceutical manufacturer.
Solovecin was approved by the FDA in June 2025 and is a bioequivalent product to Convenia (Zoetis Inc)
- Indicated for treatment of canine skin infections, caused by susceptible strains of Staphylococcus intermedius and Streptococcus canis (group G)
- Also available: Cefovecin Sodium for Injection by Qilu Animal Health Products Co, approved by the US FDA on June 24, 2025
Author's summary: New injectable therapy for skin infections in dogs and cats.